[The parenteral drug addict in the emergency service] NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[The parenteral drug addict in the emergency service]

An Med Interna. 1991 Oct;8(10):477-80. Unique Identifier : AIDSLINE MED/92089387
Lahoz Rallo C; Mostaza Prieto JM; Valencia Ortega ME; Fernandez Martin J; Michan Dona A; Juarez Alonso S; Servicio de Medicina Interna (Seccion Urgencias), Hospital; General La Paz, Madrid.

Abstract: Clinical and epidemiological features of intravenous drug addicts (IVDA), who attended the emergency department between 1984 and 1988, were studied. The number of cases treated over these 4 years had increased three-fold (256 vs 724). The median age had increased by 3 years (p less than 0.01). The sex ratio had not changed. A third of the cases knew that they were HIV-seropositive in 1988. The main reason for consultation in 1984 was overdosage and in 1988 it was fever. The rate of admission was similar in both years (around 21%). There was a significant increase in admissions caused by respiratory diseases in 1988 (p less than 0.0001) and a significant decrease of admissions caused by overdosage (p less than 0.001).
Keywords: Age Factors Chi-Square Distribution Comparative Study Diacetylmorphine/ADVERSE EFFECTS Emergencies *Emergency Service, Hospital/STATISTICS & NUMER DATA English Abstract Heroin Dependence/COMPLICATIONS/EPIDEMIOLOGY Human HIV Seropositivity/EPIDEMIOLOGY Overdose/EPIDEMIOLOGY/ETIOLOGY Retrospective Studies Sex Factors Spain Substance Abuse, Intravenous/COMPLICATIONS/*EPIDEMIOLOGY Substance Withdrawal Syndrome/EPIDEMIOLOGY/ETIOLOGY JOURNAL ARTICLEKWDagefactorschi-squaredistributioncomparativestudydiacetylmorphine/adverseeffectsemergencies
920430
M9240911

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .